Evidence map›Paper›PMID 29228708›Full record

ArticleOncotarget2017

Blood biomarkers in adults with lymph node enlargement contribute to diagnostic significance of malignancy.

Shanshan Ma, Junbin Guo, Danlei Lu, Lixia Zhu, Meng Zhou, De Zhou, Li Li, Jingjing Zhu, Xiudi Yang, Yanlong Zheng and 2 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 81% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Shanshan Ma *Department of Hematology, the First Affiliated Hospital of Medical School of Zhejiang University, Zhejiang, Hangzhou, China.
Junbin Guo *Department of Hematology, the First Affiliated Hospital of Medical School of Zhejiang University, Zhejiang, Hangzhou, China.
Danlei LuDepartment of Hematology, the First Affiliated Hospital of Medical School of Zhejiang University, Zhejiang, Hangzhou, China.
Lixia ZhuDepartment of Hematology, the First Affiliated Hospital of Medical School of Zhejiang University, Zhejiang, Hangzhou, China.
Meng ZhouDepartment of Hematology, the First Affiliated Hospital of Medical School of Zhejiang University, Zhejiang, Hangzhou, China.
De ZhouDepartment of Hematology, the First Affiliated Hospital of Medical School of Zhejiang University, Zhejiang, Hangzhou, China.
Li LiDepartment of Hematology, the First Affiliated Hospital of Medical School of Zhejiang University, Zhejiang, Hangzhou, China.
Jingjing ZhuDepartment of Hematology, the First Affiliated Hospital of Medical School of Zhejiang University, Zhejiang, Hangzhou, China.
Xiudi YangDepartment of Hematology, the First Affiliated Hospital of Medical School of Zhejiang University, Zhejiang, Hangzhou, China.
Yanlong ZhengDepartment of Hematology, the First Affiliated Hospital of Medical School of Zhejiang University, Zhejiang, Hangzhou, China.
Xiujin YeDepartment of Hematology, the First Affiliated Hospital of Medical School of Zhejiang University, Zhejiang, Hangzhou, China.
Wanzhuo XieDepartment of Hematology, the First Affiliated Hospital of Medical School of Zhejiang University, Zhejiang, Hangzhou, China.
First Affiliated Hospital Zhejiang University · CNThe First People's Hospital of Wenling · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lymph node enlargement is a common presentation and has a possibility of malignancy like lymphoma that requires early diagnosis. This study aims to analyze the clinical characteristics of these patients and finds out useful predictors of malignant diseases. We retrospectively investigated 81 patients with lymph node enlargement between July 2, 2014 and May 17, 2016. The characteristics and laboratory findings were evaluated combining with the final diagnosis. The diagnoses were malignancy in 51 patients and benign lymphadenopathy in 30 patients. Increased beta2-microglobulin (B2M) (

Indexed as

blood biomarkercytokinediagnosislymph node enlargementlymphoma

Identifiers

PMID29228708
PMCPMC5716748
OpenAlexW2766237110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.